X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Procter & Gamble Health with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs TEVA PHARMA (Israel) - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   TEVA PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
TEVA PHARMA
Dec-13
PROCTER & GAMBLE HEALTH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,5492,992-   
Low Rs1,3012,599-   
Sales per share (Unadj.) Rs511.41,717.3-  
Earnings per share (Unadj.) Rs61.3107.3-  
Cash flow per share (Unadj.) Rs74.0246.1-  
Dividends per share (Unadj.) Rs440.0093.91-  
Dividend yield (eoy) %18.13.4 540.1%  
Book value per share (Unadj.) Rs927.81,907.6-  
Shares outstanding (eoy) m16.60848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.71.6 291.3%   
Avg P/E ratio x39.626.1 151.8%  
P/CF ratio (eoy) x32.811.4 288.4%  
Price / Book Value ratio x2.61.5 178.3%  
Dividend payout %717.987.5 820.1%   
Avg Mkt Cap Rs m40,2572,370,932 1.7%   
No. of employees `0001.144.9 2.5%   
Total wages/salary Rs m1,3130-   
Avg. sales/employee Rs Th7,486.732,402.1 23.1%   
Avg. wages/employee Rs Th1,157.60-   
Avg. net profit/employee Rs Th897.22,024.1 44.3%   
INCOME DATA
Net Sales Rs m8,4901,456,311 0.6%  
Other income Rs m2440-   
Total revenues Rs m8,7341,456,311 0.6%   
Gross profit Rs m1,482398,811 0.4%  
Depreciation Rs m211117,715 0.2%   
Interest Rs m028,604 0.0%   
Profit before tax Rs m1,514252,492 0.6%   
Minority Interest Rs m01,147 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m66-165,747 -0.0%   
Tax Rs m563-3,083 -18.2%   
Profit after tax Rs m1,01790,975 1.1%  
Gross profit margin %17.527.4 63.7%  
Effective tax rate %37.1-1.2 -3,042.5%   
Net profit margin %12.06.2 191.8%  
BALANCE SHEET DATA
Current assets Rs m15,343983,587 1.6%   
Current liabilities Rs m1,960857,771 0.2%   
Net working cap to sales %157.68.6 1,824.6%  
Current ratio x7.81.1 682.6%  
Inventory Days Days4991 53.7%  
Debtors Days Days2896 29.7%  
Net fixed assets Rs m1,209475,663 0.3%   
Share capital Rs m1663,585 4.6%   
"Free" reserves Rs m15,2350-   
Net worth Rs m15,4011,617,685 1.0%   
Long term debt Rs m0744,644 0.0%   
Total assets Rs m17,5953,328,137 0.5%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 110.3%   
Return on assets %5.83.6 160.9%  
Return on equity %6.65.6 117.5%  
Return on capital %10.34.9 208.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,7320-   
CASH FLOW
From Operations Rs m-1,304232,061 -0.6%  
From Investments Rs m12,697-82,228 -15.4%  
From Financial Activity Rs m-301-278,372 0.1%  
Net Cashflow Rs m11,093-128,540 -8.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.69 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PROCTER & GAMBLE HEALTH With: STRIDES PHARMA SCIENCE  ABBOTT INDIA  FDC LTD.  NOVARTIS  SUN PHARMA  



Today's Market

Of Falling Stocks, Tumbling Rupee and Weakening Economy(Podcast)

Another week of slowdown in the markets over fears of a looming slowdown in the domestic and global economy continue.

Related Views On News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Interest Rates Are Low. Buy Solid Dividend Stocks Instead (The 5 Minute Wrapup)

Aug 13, 2019

The dividends paid by these stocks are helpful when interest rates are falling.

Smallcaps that Will Outperform in the Market Rebound (Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

My Top 3 Dividend Stocks to Buy Now (Profit Hunter)

Aug 19, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Chandrayaan 2 Heads to the Moon and It's Good News for These Stocks (The 5 Minute Wrapup)

Aug 14, 2019

Why investors should take note of India's advantage as a low cost satellite launcher...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Aug 23, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - NATCO PHARMA COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS